IP Library › Granted Patent US 10,519,203
Granted Patent B2
US 10,519,203 · App. 15/712,172 · Granted Dec 31, 2019

Gene for biosynthesis of core structure of ophiobolin

Inventors: Kui Hong (Wuhan, CN); Huiying Meng (Wuhan, CN); Hangzhen Chai (Wuhan, CN); Ru Yin (Wuhan, CN); Zixin Deng (Wuhan, CN)
Assignee: WUHAN UNIVERSITY
C07K14/38C12N9/10C12N9/1085C12P7/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,519,203
App. No.
15/712,172
Granted
Dec 31, 2019
Kind
B2
Abstract

A gene for biosynthesis of core structure of ophiobolin, the gene being the AuOS gene of Aspergillus sp. 094102, deposited with the accession number CCTCC No: M208153, the gene sequence thereof being shown as SEQ ID NO. 1. Also provided is a method of preparation of ophiobolin using the gene.

Claims (17)

1. A cDNA, wherein the cDNA comprises the nucleic acid sequence of SEQ ID NO: 2.

2. A method for preparing an ophiobolin precursor, the method comprising:

1) extracting RNA from mycelia of Aspergillus sp. 094102 which has been deposited in China Center for Type Culture Collection (CCTCC) with an accession number: CCTCC NO. M208153;

2) reverse-transcribing the RNA of 1) into a cDNA;

3) conducting PCR amplification of the cDNA of 2) with a pair of primers to obtain a PCR product mixture;

4) recovering a target DNA fragment from the PCR product mixture of 3), wherein the target DNA fragment comprises the nucleic acid sequence of SEQ ID NO: 2 ligated to recognition sites of restriction enzymes Nde I and Hind III;

5) ligating the target DNA fragment into a first vector to obtain a first recombinant plasmid;

6) digesting the target DNA fragment from the first recombinant plasmid of 5) and inserting the target DNA fragment into a second vector to obtain a second recombinant plasmid;

7) transforming the second recombinant plasmid of 6) into Escherichia coli BL21 to obtain an engineered Escherichia coli strain;

8) cultivating the engineered Escherichia coli strain of 7) to obtain a target protein encoded by the target DNA fragment;

9) purifying the target protein; and

10) in vitro synthesizing an ophiobolin precursor from a first substrate and a second substrate using the target protein as a catalyst, wherein the first substrate is selected from dimethylallyl diphosphate, geranyl diphosphate, farnesyl diphosphate, and geranylgeranyl diphosphate, the second substrate is isopentenyl diphosphate, and the ophiobolin precursor has a molecular structure as follows:

3. The method of claim 2 , wherein the pair of primers of 3) comprise the nucleic acid sequence of each of SEQ ID NO: 4 and SEQ ID NO: 5, respectively.

4. A recombinant plasmid, wherein:

the engineered plasmid is a pET28a vector comprising a target DNA sequence; and

the target DNA sequence comprises the nucleic acid sequence of SEQ ID NO: 2.

5. An engineered Escherichia coli strain, the engineered Escherichia coli strain comprising the recombinant plasmid of claim 4 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2017
From: HONG, KUI; MENG, HUIYING; CHAI, HANGZHEN; YIN, RU; DENG, ZIXIN
To: WUHAN UNIVERSITY
Reel/Frame 043675/0632 →
Priority Claims (1)
CN 2015 1 0130163 · Mar 24, 2015 · national
Continuity (2)
Continuation In Part PCTCN2016076822 · Mar 21, 2016
Related Publication 20180009855A1 · Jan 11, 2018